Showing 15 posts of 108 posts found.

Probiotics have no effect on children with gastroenteritis, study shows

November 22, 2018
Research and Development children, flu, gastroenteritis, probiotics, research

Despite the claims of marketing campaigns and advertisements, probiotics have no effect on gastroenteritis on children, according to a new …


76% of patients no longer experience PTSD a year after MDMA-assisted psychotherapy

November 6, 2018
Manufacturing and Production, Research and Development MDMA, PTSD, mental health, psychotherapy, research

Promising phase II results suggest that MDMA-assisted psychotherapy may be an “innovative, efficacious treatment for posttraumatic stress disorder,” according to …


Novartis cuts 20% of research projects

November 1, 2018
Business Services, Research and Development Business, Novartis, gene therapy, infectious diseases, research

Swiss multinational Novartis has cut a fifth of its research projects, as it abandons 90 of its 430 drug development …


UK Dementia partnership offering £100,000-200,000 awards for dementia research projects

October 23, 2018
Manufacturing and Production Alzheimer's, dementia, development, research

The Dementia Discovery Fund (DDF) in partnership with the UK Dementia Research Institute (UK DRI) has announced that it will …


AI, big data: Making a case for faster drug discovery

October 15, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Big Data, feature, healthcare, research

They’re two of the biggest buzzwords getting professionals excited across pharma – Anjali Shukla explores the ways in which AI …

Health innovation system is broken and failing patients, new report argues

October 15, 2018
Sales and Marketing IP, industry, intellectual property, priofit, research

The pharmaceutical industry is incentivised to set high prices and deliver short-term returns to shareholders, rather than focusing on riskier, …

Chanelle Pharma announces €86m investment over next five years

October 12, 2018
Medical Communications Ireland, chanelle, generics, investment, research

Chanelle Pharmaceuticals, one of the largest Irish-owned pharmaceutical companies in Ireland, have announced an €86 million investment programme over the …


Increased funding and research could help address unmet mental health needs

October 10, 2018
Research and Development funding, global data, mental health, research

Unmet needs relating to mental health could be met through increasing funding and research, according to data analytics firm GlobalData. …


WHO voices concern over British immigration policies after researchers refused entry

October 10, 2018
Research and Development WHO, academia, immigration, research, universities

The World Health Organization (WHO) has expressed concern over the UK’s immigration polices, after a number of academics were refused …


NICE guidelines on antidepressant withdrawal symptoms are misleading, study shows

October 9, 2018
Manufacturing and Production NICE, UK, addiction, antidepressants, research, study

Current NICE guidance concerning the severity of the effects of antidepressant withdrawal is misleading doctors according to research published in …


Clinical trial halted because of Brexit, UK Government downplays concerns

October 3, 2018
Research and Development UK, brexit, clinical trials, politics, research

A clinical trial looking into the safety and efficacy of the drug dutogliptin has been halted due to uncertainties surrounding …

European countries unprepared for Alzheimer’s innovations, study shows

October 1, 2018
Sales and Marketing Alzheimer's dementia, Alzheimer’s & dementia, EU, Euroepan Union, RAND corporation, research

European healthcare systems are not prepared for new developments in preventative therapies for Alzheimer’s disease, according to research conducted by …


Antibody therapy supresses HIV for months after treatment, study shows

October 1, 2018
Sales and Marketing HIV, immunology, immunotherapy, nature, research

Researchers from the New York City based Rockefeller University have developed a novel immunotherapy, which is capable of suppressing HIV …


Ipsen appoints two leading R&D experts in bid to strengthen oncology arm

September 28, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, R&D, development, ipsen, oncology, research

French pharma firm Ipsen has announced the appointment of Dr. Yan Moore as Senior Vice President, Head of Oncology Therapeutic …


Takeda’s lung cancer treatment Alunbrig proves successful in Phase III trial

September 26, 2018
Research and Development Alunbrig, R&D, Takeda, phase III, research

Japanese pharma firm Takeda have announced that lung cancer treatment Alunbrig has proven successful in reducing the risk of disease …

Latest content